596 related articles for article (PubMed ID: 9504386)
1. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
Corradetti R; Le Poul E; Laaris N; Hamon M; Lanfumey L
J Pharmacol Exp Ther; 1996 Aug; 278(2):679-88. PubMed ID: 8768719
[TBL] [Abstract][Full Text] [Related]
3. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices.
Pugliese AM; Passani MB; Corradetti R
Br J Pharmacol; 1998 May; 124(1):93-100. PubMed ID: 9630348
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro.
Corradetti R; Mlinar B; Falsini C; Pugliese AM; Cilia A; Destefani C; Testa R
J Pharmacol Exp Ther; 2005 Oct; 315(1):109-17. PubMed ID: 15951403
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of WAY 100635, a new 5-HT1A receptor antagonist, on dorsal raphe nucleus serotoninergic neurones and CA1 pyramidal cells in vitro.
Corradetti R; Pugliese AM; Le Poul E; Laaris N; Hamon M; Lanfumey L
Acta Physiol Hung; 1996; 84(4):407-9. PubMed ID: 9328615
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
Haddjeri N; de Montigny C; Blier P
Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
[TBL] [Abstract][Full Text] [Related]
8. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
[TBL] [Abstract][Full Text] [Related]
10. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
Haddjeri N; Blier P
J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
[TBL] [Abstract][Full Text] [Related]
11. Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain.
Haddjeri N; Blier P
Synapse; 1995 May; 20(1):54-67. PubMed ID: 7624830
[TBL] [Abstract][Full Text] [Related]
12. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
Bermack JE; Debonnel G
J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864
[TBL] [Abstract][Full Text] [Related]
13. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
Lejeune F; Millan MJ
Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
Martin LP; Jackson DM; Wallsten C; Waszczak BL
J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo.
Clifford EM; Gartside SE; Umbers V; Cowen PJ; Hajós M; Sharp T
Br J Pharmacol; 1998 May; 124(1):206-12. PubMed ID: 9630361
[TBL] [Abstract][Full Text] [Related]
16. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
[TBL] [Abstract][Full Text] [Related]
17. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
[TBL] [Abstract][Full Text] [Related]
18. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
19. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
Sprouse J; Braselton J; Reynolds L
Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804
[TBL] [Abstract][Full Text] [Related]
20. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
Blier P; Lista A; De Montigny C
J Pharmacol Exp Ther; 1993 Apr; 265(1):7-15. PubMed ID: 8474032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]